| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4036091
[patent_doc_number] => 05856317
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Methods of treatment'
[patent_app_type] => 1
[patent_app_number] => 8/653551
[patent_app_country] => US
[patent_app_date] => 1996-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3759
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856317.pdf
[firstpage_image] =>[orig_patent_app_number] => 653551
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/653551 | Methods of treatment | May 23, 1996 | Issued |
Array
(
[id] => 3886542
[patent_doc_number] => 05776947
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Use of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shock'
[patent_app_type] => 1
[patent_app_number] => 8/586857
[patent_app_country] => US
[patent_app_date] => 1996-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 3598
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776947.pdf
[firstpage_image] =>[orig_patent_app_number] => 586857
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/586857 | Use of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shock | May 19, 1996 | Issued |
Array
(
[id] => 3869748
[patent_doc_number] => 05837734
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Method for the treatment of coccidioidomycosis in warm-blooded animals'
[patent_app_type] => 1
[patent_app_number] => 8/640606
[patent_app_country] => US
[patent_app_date] => 1996-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5265
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837734.pdf
[firstpage_image] =>[orig_patent_app_number] => 640606
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/640606 | Method for the treatment of coccidioidomycosis in warm-blooded animals | Apr 30, 1996 | Issued |
Array
(
[id] => 3793357
[patent_doc_number] => 05726196
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-10
[patent_title] => 'Aromatase-inhibiting composition containing azole derivative'
[patent_app_type] => 1
[patent_app_number] => 8/623914
[patent_app_country] => US
[patent_app_date] => 1996-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6227
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/726/05726196.pdf
[firstpage_image] =>[orig_patent_app_number] => 623914
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/623914 | Aromatase-inhibiting composition containing azole derivative | Mar 27, 1996 | Issued |
| 08/625410 | "COMBINATION THERAPY (TEMOZOLOMIDE AND ALPHA-IFN) FOR ADVANCED CANCER | Mar 26, 1996 | Abandoned |
| 08/624795 | COMBINATION THERAPY FOR ADVANCED CANCER | Mar 26, 1996 | Abandoned |
Array
(
[id] => 3761281
[patent_doc_number] => 05843929
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Chemoprevention of metachronous adenomatous colorectal polyps'
[patent_app_type] => 1
[patent_app_number] => 8/621781
[patent_app_country] => US
[patent_app_date] => 1996-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4707
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843929.pdf
[firstpage_image] =>[orig_patent_app_number] => 621781
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/621781 | Chemoprevention of metachronous adenomatous colorectal polyps | Mar 21, 1996 | Issued |
| 08/618762 | METHOD FOR INHIBITING MAMMALIAN CELL PROLIFERATION | Mar 19, 1996 | Abandoned |
Array
(
[id] => 3928420
[patent_doc_number] => 05877215
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'Method of treating neoplastic cells with prostaglandin and radiation treatment or prostaglandin and platinum-based anti-tumor agents'
[patent_app_type] => 1
[patent_app_number] => 8/619854
[patent_app_country] => US
[patent_app_date] => 1996-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9783
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/877/05877215.pdf
[firstpage_image] =>[orig_patent_app_number] => 619854
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/619854 | Method of treating neoplastic cells with prostaglandin and radiation treatment or prostaglandin and platinum-based anti-tumor agents | Mar 19, 1996 | Issued |
Array
(
[id] => 3798944
[patent_doc_number] => 05827892
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-27
[patent_title] => 'Use of droloxifene for the treatment of cardiovascular diseases'
[patent_app_type] => 1
[patent_app_number] => 8/605131
[patent_app_country] => US
[patent_app_date] => 1996-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1235
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/827/05827892.pdf
[firstpage_image] =>[orig_patent_app_number] => 605131
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/605131 | Use of droloxifene for the treatment of cardiovascular diseases | Mar 12, 1996 | Issued |
| 08/605172 | ANTIFUNGAL ANTIBIOTIC, AND NEW BACILLUS SP. MICROORGANISM WHICH CAN PRODUCE THE ABOVE ANTIBIOTIC AND ITS MANUFACTURING METHOD | Mar 10, 1996 | Abandoned |
Array
(
[id] => 4022823
[patent_doc_number] => 05925633
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-20
[patent_title] => '3-Substituted-4-oxa-1-azabicyclo ›3,2,0!heptan-7-one as cysteine protease inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/611946
[patent_app_country] => US
[patent_app_date] => 1996-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9510
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 871
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/925/05925633.pdf
[firstpage_image] =>[orig_patent_app_number] => 611946
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/611946 | 3-Substituted-4-oxa-1-azabicyclo ›3,2,0!heptan-7-one as cysteine protease inhibitors | Mar 5, 1996 | Issued |
Array
(
[id] => 4248913
[patent_doc_number] => 06136857
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => 'Methods for treating neoplasms with betaines'
[patent_app_type] => 1
[patent_app_number] => 8/610908
[patent_app_country] => US
[patent_app_date] => 1996-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 6902
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/136/06136857.pdf
[firstpage_image] =>[orig_patent_app_number] => 610908
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/610908 | Methods for treating neoplasms with betaines | Mar 4, 1996 | Issued |
Array
(
[id] => 3827440
[patent_doc_number] => 05783599
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-21
[patent_title] => 'Methods of treating cancer and viral infections with 5-iodo-6-amino-and 5-iodo-6-nitroso-1 2-benzopyrones'
[patent_app_type] => 1
[patent_app_number] => 8/607480
[patent_app_country] => US
[patent_app_date] => 1996-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 14424
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/783/05783599.pdf
[firstpage_image] =>[orig_patent_app_number] => 607480
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/607480 | Methods of treating cancer and viral infections with 5-iodo-6-amino-and 5-iodo-6-nitroso-1 2-benzopyrones | Feb 26, 1996 | Issued |
Array
(
[id] => 3890636
[patent_doc_number] => 05834455
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-10
[patent_title] => 'Photosensitizers for sensitizing cells'
[patent_app_type] => 1
[patent_app_number] => 8/596287
[patent_app_country] => US
[patent_app_date] => 1996-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4935
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/834/05834455.pdf
[firstpage_image] =>[orig_patent_app_number] => 596287
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/596287 | Photosensitizers for sensitizing cells | Feb 12, 1996 | Issued |
Array
(
[id] => 4383412
[patent_doc_number] => 06262054
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Combination therapy method for treating breast cancer using edatrexate'
[patent_app_type] => 1
[patent_app_number] => 8/595352
[patent_app_country] => US
[patent_app_date] => 1996-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4331
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/262/06262054.pdf
[firstpage_image] =>[orig_patent_app_number] => 595352
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/595352 | Combination therapy method for treating breast cancer using edatrexate | Jan 31, 1996 | Issued |
Array
(
[id] => 3657564
[patent_doc_number] => 05622972
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'Method for treating a mammal infected with respiratory syncytial virus'
[patent_app_type] => 1
[patent_app_number] => 8/585603
[patent_app_country] => US
[patent_app_date] => 1996-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8682
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/622/05622972.pdf
[firstpage_image] =>[orig_patent_app_number] => 585603
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/585603 | Method for treating a mammal infected with respiratory syncytial virus | Jan 25, 1996 | Issued |
Array
(
[id] => 3770315
[patent_doc_number] => 05733911
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-31
[patent_title] => 'Method for inducing death of neoplastic cells using piperazne derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/592540
[patent_app_country] => US
[patent_app_date] => 1996-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 39
[patent_no_of_words] => 10938
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/733/05733911.pdf
[firstpage_image] =>[orig_patent_app_number] => 592540
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/592540 | Method for inducing death of neoplastic cells using piperazne derivatives | Jan 25, 1996 | Issued |
Array
(
[id] => 3871994
[patent_doc_number] => 05763442
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-09
[patent_title] => 'Anti-parasitic activity'
[patent_app_type] => 1
[patent_app_number] => 8/591032
[patent_app_country] => US
[patent_app_date] => 1996-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5059
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/763/05763442.pdf
[firstpage_image] =>[orig_patent_app_number] => 591032
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/591032 | Anti-parasitic activity | Jan 24, 1996 | Issued |
Array
(
[id] => 3949398
[patent_doc_number] => 05955424
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs'
[patent_app_type] => 1
[patent_app_number] => 8/580993
[patent_app_country] => US
[patent_app_date] => 1996-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2800
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955424.pdf
[firstpage_image] =>[orig_patent_app_number] => 580993
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/580993 | Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs | Jan 2, 1996 | Issued |